Source: International Congress 2015 – IPF: from bench to bedside
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
So Ri Kim (Jeonju, Republic of Korea), So Ri Kim, Yong Chul Lee, Dong Im Kim, Hae Jin Park, Soon Ha Kim. Inhaled PHMG can induce pulmonary fibrosis through mitochondrial ROS generation. Eur Respir J 2015; 46: Suppl. 59, 3046

Member's Comments

No comment yet.

Related content which might interest you: Interaction between mitochondrial ROS and ER stress on PHMG-induced pulmonary fibrosis Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Effects of hydrogen sulfide on ozone-induced features of chronic obstructive pulmonary disease Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models Year: 2015 Increased levels of oxidative stress markers in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 Treprostinil administration attenuates bleomycin-induced lung fibrosis in mice Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Measurement of alveolar nitric oxide in IPF patients and in healthy controls Source: International Congress 2014 – ILDs 4 Year: 2014 Novel biomarkers in bleomycin-induced pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 PP215 – The effect of long-term personal air pollution exposure on the inflammatory mediators in Idiopathic Pulmonary Fibrosis Source: ERS Lung Science Conference 2021 Year: 2021 Increased fibrinolytic mediators in IPF as potential contributors to pulmonary fibrosis and vascular remodeling Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Enhanced interleukin-18 expression in rodent models of quartz induced fibrosis Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models Year: 2015 Induction of TGF-β and reactive oxygen species expression in bronchial epithelial cell by urban ambient air particulate matter Source: Annual Congress 2006 - Pulmonary fibrosis: pathophysiology and therapeutic approaches Year: 2006 Pirfenidone attenuates myofibroblast differentiation during insufficient mitophagy Source: International Congress 2016 – IPF pathogenesis Year: 2016 Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases Source: International Congress 2015 – IIPs: orphan Year: 2015 Mucus production, lung inflammation and functional decay in IPF Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Hypoxic challenge testing in idiopathic pulmonary fibrosis Source: International Congress 2016 – Orphan diseases I Year: 2016 No effect of baseline diffusing capacity of lung for carbon monoxide on benefit of nintedanib Source: International Congress 2016 – IPF treatment II Year: 2016 Markers of injury and fibrosis in occupational interstitial lung diseases (OILD) Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 LSC - 2021 - The effect of long-term personal air pollution exposure on the inflammatory mediators in Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2021 – The future of idiopathic pulmonary fibrosis Year: 2021 Tranilast inhibits pulmonary fibrosis by suppressing TGFbeta-mediated extracellular matrix protein production Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 17(R)-resolvinD1 improves MMP-9/TIMP-1 imbalance leading to amelioration of pulmonary fibrosis in mice Source: International Congress 2016 – ILD pathogenesis Year: 2016 Effects of NecroX compounds on bleomycin-induced pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016